Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W. Valle, John Bridgewater, Marian Duggan et al.|The Lancet Oncology|2015Cited by 282
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trialAlison Backen, Juan W. Valle, Andre Lopes et al.|British Journal of Cancer|2018Cited by 26
ABC-03: A randomized phase II trial of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine (CisGem) chemotherapy for patients (pts) with advanced biliary tract cancer (ABC).Juan W. Valle, John Bridgewater, Harpreet Wasan et al.|Journal of Clinical Oncology|2014Cited by 5